Chang-ming Huang
Fuzhou, Fujian, 350001, China
NCT Number: NCT06548464
This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer.
Looking for future studies?
Notify MeAll sexes
Observational
Fuzhou, Fujian, 350001, China
This multicenter, retrospective cohort study aimed to develop and validate an explainable prediction model for prognosis after gastrectomy in patients with gastric cancer. The study included patients who underwent radical gastrectomy for primary gastric or gastroesophageal junction cancer across multiple institutions in China.
The primary objective was to create a machine learning-based model to predict postoperative outcomes following gastrectomy, using readily available clinical and pathological parameters. The main outcome of interest was early recurrence within 2 years after surgery, which significantly impacts overall prognosis.
The study employed various machine learning algorithms to develop prediction models, which were then compared and validated. Model performance was assessed through measures such as area under the receiver operating characteristic curve (AUC), calibration, and Brier score. The SHapley Additive exPlanations (SHAP) method was used to interpret the model and rank feature importance.
This research aims to provide clinicians with a tool for identifying patients at higher risk of poor postoperative outcomes who may benefit from more intensive post-operative monitoring and early intervention strategies, potentially improving prognosis for gastric cancer patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 5 years after surgery
Assessment of overall survival outcomes in gastric cancer patients after gastrectomy.
Time frame: Within 2 years after surgery
Incidence of cancer recurrence within 2 years after gastrectomy.
Time frame: From 2 years up to 5 years after surgery
Incidence of cancer recurrence occurring more than 2 years after gastrectomy.
Time frame: Within 30 days after surgery
Incidence and severity of complications following gastrectomy.
Time frame: From initiation of neoadjuvant therapy to surgery (typically 2-3 months)
Assessment of tumor response to neoadjuvant therapy before gastrectomy.
Time frame: 5 years after surgery
Percentage of patients alive 5 years after gastrectomy.
Chang-Ming Huang, Prof.
Other
Development and Validation of Interpretable Machine Learning Models for Prognosis in Gastric Cancer Patients: a Multicenter Retrospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07682220
Behavior, Digestive System Diseases
Harbin, Heilongjiang, China
View Trial DetailsNCT05334719
Digestive System Diseases, Digestive System Neoplasms
Minato-ku, Tokyo, Japan
View Trial DetailsNCT03030404
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT03675737
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial Details